Surzen Biotherapeutics
Surzen Biotherapeutics is developing peptide therapeutics that enhance the effectiveness of opioid analgesics.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredAug 31, 2025 (15 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | — |
Timeline
- Website created
Founders and team
PZ
Peng Zhou Founder
Companies like Surzen Biotherapeutics
Ccounterx therapeuticsSeed · Sep 2026
PPETESeed · Apr 2026
LLassen Therapeutics$85M Series B+ · Jan 2024
RRevolver Therapeutics$763.3K Pre Seed · Jul 2026
SSapience Therapeutics$41M Series B+ · Jun 2022
PPeptarisSeed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/surzen-biotherapeutics (get a free API key).